Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

ClinicalTrials.gov ID: NCT00099320

Public ClinicalTrials.gov record NCT00099320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 12:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00099320
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
182 participants

Conditions and interventions

Interventions

  • exenatide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2004
Primary completion
Jul 31, 2005
Completion
Jul 31, 2005
Last update posted
Feb 22, 2015

2004 – 2005

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
40
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site La Jolla California
Research Site San Mateo California
Research Site Santa Barbara California
Research Site Spring Valley California
Research Site Hialeah Florida
Research Site Jacksonville Florida
Research Site Melbourne Florida
Research Site West Palm Beach Florida
Research Site Atlanta Georgia
Research Site Honolulu Hawaii
Research Site Idaho Falls Idaho
Research Site Chicago Illinois
Research Site Baton Rouge Louisiana
Research Site Kalamazoo Michigan
Research Site Troy Michigan
Research Site Butte Montana
Research Site McCook Nebraska
Research Site North Platte Nebraska
Research Site Omaha Nebraska
Research Site Scottsbluff Nebraska
Research Site Princeton New Jersey
Research Site Albuquerque New Mexico
Research Site Albany New York
Research Site New York New York
Research Site Rochester New York
Research Site Greenville North Carolina
Research Site Cleveland Ohio
Research Site Greenville South Carolina
Research Site Chattanooga Tennessee
Research Site Knoxville Tennessee
Research Site Dallas Texas
Research Site Georgetown Texas
Research Site San Antonio Texas
Research Site The Colony Texas
Research Site Olympia Washington
Research Site Renton Washington
Research Site Tacoma Washington
Research Site Charleston West Virginia
Research Site Huntington West Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00099320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2015 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00099320 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →